Cencora, Inc. (LON:0HF3)
371.59
+10.38 (2.87%)
Feb 12, 2026, 4:54 PM GMT
Cencora Market Cap
Cencora has a market cap or net worth of 52.14 billion as of February 12, 2026. Its market cap has increased by 31.12% in one year.
Market Cap
52.14B
Enterprise Value
58.25B
Revenue
242.05B
Ranking
n/a
PE Ratio
43.18
Stock Price
371.59
Market Cap Chart
Since April 4, 1995, Cencora's market cap has increased from 199.85M to 52.14B, an increase of 25,989.20%. That is a compound annual growth rate of 19.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 52.14B | 7.10% |
| Dec 31, 2025 | 48.68B | 40.35% |
| Dec 31, 2024 | 34.69B | 8.10% |
| Dec 29, 2023 | 32.09B | 15.46% |
| Dec 30, 2022 | 27.79B | 36.06% |
| Dec 31, 2021 | 20.43B | 39.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 229.82B |
| GSK plc | 87.00B |
| Haleon | 36.19B |
| Smith & Nephew | 10.94B |
| Convatec Group | 4.29B |
| Hikma Pharmaceuticals | 3.44B |
| Genus | 2.09B |
| HUTCHMED (China) | 1.88B |